FKBP10 and central nervous system cancer: Strong FKBP10 immunostaining was positively related to poor prognosis in both grades 3 (HR = 2.06, 95% CI 1.08–3.91, P = 0.024) and 4 gliomas (HR = 1.80, 95% CI 1.27–2.52, P = 0.0007, Fig. 1c, d).